Objective: To report a case of neuro retinitis in ocular
bartonellosis which showed good response to topical nepafenac
0.1%, a non-steroidal anti-inflammatory drug, in addition to the
standard treatment of systemic antibiotics.
Result: A 14 year-old boy with history of cat scratch and fever
prior to painless reduced vision of the left eye was clinically
diagnosed as neuro retinitis characterized by optic disc swelling
with subsequent development of macular star. He was started on
topical nepafenac 0.1% which showed an improvement in visual
acuity over 3 days. Oral azithromycin was subsequently started to
treat the underlying cause neuro retinitis. Serologic examination
for Bartonella henselae was positive for both immunoglobulin M
and G. Patient responded well to treatment with final visual
outcome of 6/6 and serial optical coherent tomography (OCT) of
the macula showing resolution of macular edema at one month.
Conclusion: Usage of topical nepafenac in combination with
systemic antibiotics appears to be beneficial and hastens the
visual recovery of patient. Further studies are needed to
investigate the role of topical nepafenac as an alternative to
systemic corticosteroids in cases of neuro retinitis in ocular
bartonellosis.
Open Access
Peer Reviewed
ISSN: 2381-5000
Aperito Journal of Ophthalmology
International open-access publishing for high-quality research, reviews, case studies, and scholarly communication.
Submit Manuscript
Original Research
Article in Press
Topical NSAID an Option for Early Resolution of Macula Edema in Neuroretinitis? : A Case Report
Chee Kuen Wong1, 2*, Shirlyna N1,2 , Adil Hussein1,2 and Wan Hazabbah Wan Hitam1,2
Corresponding Author: Chee Kuen Wong,
Received: Aug 26, 2016
Accepted: Aug 30, 2016
Published: Sep 02, 2016
Views: 3
DOI: N/A
Abstract
Chee Kuen Wong et al. (2016), Topical NSAID an Option for Early Resolution of Macula Edema in Neuroretinitis? : A Case
Report. Aperito J Ophthalmol 2:123
Copyright:
Copyright: © 2016 AJO. This is an open-access article distributed under the terms of the Creative Commons Attribution License, Version 3.0, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original author and source are credited.
distribution, and reproduction in any medium, provided the original author and source are credited.
Indexed In
Google Scholar
DOAJ
PubMed
Scopus